Collplant Biotechnologies Ltd - ADR (CLGN) is higher by 0.13% in a Week, Should You Sell?

The 64 rating InvestorsObserver gives to Collplant Biotechnologies Ltd - ADR (CLGN) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 76 percent of stocks in the Biotechnology industry, CLGN’s 64 overall rating means the stock scores better than 64 percent of all stocks.

CLGN has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on CLGN!

See Full CLGN Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 64 means the stock is more attractive than 64 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Collplant Biotechnologies Ltd - ADR Stock Today?

Collplant Biotechnologies Ltd - ADR (CLGN) stock is higher by 6.85% while the S&P 500 is lower by -0.04% as of 10:31 AM on Tuesday, Apr 4. CLGN has gained $0.48 from the previous closing price of $7.01 on volume of 7,091 shares. Over the past year the S&P 500 has fallen -10.03% while CLGN is lower by -31.85%. CLGN lost -$1.49 per share the over the last 12 months. Click Here to get the full Stock Report for Collplant Biotechnologies Ltd - ADR stock.